CD4+ T-Cells Infiltrate Hypocretin Region in Narcolepsy Type 1

Narcolepsy type 1 is a chronic neurological sleep disorder characterized by excessive daytime sleepiness and cataplexy, driven by the profound loss of neurons that produce the wake-promoting neuropeptide hypocretin, also known as orexin [1, 2]. For decades, clinicians and researchers have strongly suspected an autoimmune etiology for this neuronal destruction, pointing to the disease's tight association with specific human leukocyte antigen alleles and epidemiological spikes following influenza infections [1, 3]. Despite this compelling circumstantial evidence, directly observing the immune system's assault on the hypothalamus in human patients has proven exceptionally difficult [4, 5]. Consequently, most therapeutic strategies currently rely on managing symptoms rather than addressing the underlying cause of the disease [6]. Now, a recent postmortem analysis of human brain tissue offers a direct look at localized immune activity within the hypothalamus, providing physical evidence that supports the autoimmune hypothesis.